文献
J-GLOBAL ID:201902257473204527
整理番号:19A0338072
中国人集団におけるde novo MDSに対するFLT3-ITD変異の役割【JST・京大機械翻訳】
The Role of FLT3-ITD Mutation on de Novo MDS in Chinese Population
著者 (26件):
Xu Fei
(Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China)
,
Xu Fei
(Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China)
,
Han Rong
(Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China)
,
Han Rong
(Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China)
,
Zhang Jian
(Department of Blood Transfusion, The First Affiliated Hospital of Soochow University, Suzhou, China)
,
Li Zheng
(Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China)
,
Li Zheng
(Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China)
,
Wang Jun
(Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China)
,
Wang Jun
(Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China)
,
Chu Xiao-Ling
(Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China)
,
Chu Xiao-Ling
(Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China)
,
Yu Jing-Qiu
(Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China)
,
Yu Jing-Qiu
(Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China)
,
Wang Chao
(Department of Hematology, the First Affiliated Hospital of Nanyang Medical College, Nanyang, China)
,
Tao Tao
(Department of Internal Medicine, the Fifth People’s Hospital of Suzhou, Suzhou, China)
,
Shen Hong-Jie
(Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China)
,
Shen Hong-Jie
(Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China)
,
Chen Su-Ning
(Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China)
,
Chen Su-Ning
(Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China)
,
Wu De-Pei
(Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China)
,
Wu De-Pei
(Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China)
,
Liu Song-Bai
(Suzhou Key Laboratory for Medical Biotechnology, Suzhou Vocational Health College, Suzhou, China)
,
Qiu Qiao-Cheng
(Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China)
,
Qiu Qiao-Cheng
(Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China)
,
Xue Sheng-Li
(Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China)
,
Xue Sheng-Li
(Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China)
資料名:
Clinical Lymphoma Myeloma and Leukemia
(Clinical Lymphoma Myeloma and Leukemia)
巻:
19
号:
2
ページ:
e107-e115
発行年:
2019年
JST資料番号:
W3263A
ISSN:
2152-2650
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)